{{Rsnum
|rsid=10040979
|Gene=EBF1
|Chromosome=5
|position=158997383
|Orientation=plus
|GMAF=0.4587
|Gene_s=EBF1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 49.1 | 46.4 | 4.5
| HCB | 19.7 | 41.6 | 38.7
| JPT | 9.7 | 59.3 | 31.0
| YRI | 19.7 | 53.7 | 26.5
| ASW | 28.1 | 43.9 | 28.1
| CHB | 19.7 | 41.6 | 38.7
| CHD | 15.6 | 45.0 | 39.4
| GIH | 82.2 | 13.9 | 4.0
| LWK | 24.5 | 52.7 | 22.7
| MEX | 29.3 | 56.9 | 13.8
| MKK | 16.7 | 45.5 | 37.8
| TSI | 42.2 | 53.9 | 3.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=5E-7
  |OR=1.45
  |ORtxt=[1.12-1.883]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}